DTYMK
Basic information
Region (hg38): 2:241675747-241686944
Links
Phenotypes
GenCC
Source:
- neurodegeneration, childhood-onset, with progressive microcephaly (Strong), mode of inheritance: AR
- mitochondrial DNA depletion syndrome (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodegeneration, childhood-onset, with progressive microcephaly | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary; Neurologic | 31271740; 34918187 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DTYMK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 18 | 2 | 1 |
Variants in DTYMK
This is a list of pathogenic ClinVar variants found in the DTYMK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-241676149-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
2-241676173-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
2-241676174-C-T | not specified | Likely benign (Dec 06, 2022) | ||
2-241676224-G-A | not specified | Uncertain significance (Jul 26, 2021) | ||
2-241678467-C-T | Likely benign (May 01, 2023) | |||
2-241678505-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
2-241678547-C-T | not specified | Uncertain significance (Jul 31, 2023) | ||
2-241678553-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
2-241678591-A-C | not specified | Uncertain significance (Aug 08, 2024) | ||
2-241678598-C-T | Neurodegeneration, childhood-onset, with progressive microcephaly | Pathogenic (Apr 28, 2022) | ||
2-241678616-C-T | not specified | Uncertain significance (Nov 22, 2022) | ||
2-241680238-ACCGGTGAAGGCCACACCAGAAAATGCGTATCTGT-A | Neurodegeneration, childhood-onset, with progressive microcephaly | Pathogenic (Apr 28, 2022) | ||
2-241680257-G-C | not specified | Uncertain significance (Nov 21, 2023) | ||
2-241680264-C-T | Neurodegeneration, childhood-onset, with progressive microcephaly | Pathogenic (Oct 06, 2022) | ||
2-241680317-G-A | Neurodegeneration, childhood-onset, with progressive microcephaly | Pathogenic (Oct 06, 2022) | ||
2-241684718-CAACATT-C | Neurodegeneration, childhood-onset, with progressive microcephaly | Uncertain significance (Mar 26, 2024) | ||
2-241685819-C-T | Likely benign (Oct 01, 2024) | |||
2-241685825-A-C | not specified | Uncertain significance (Nov 21, 2023) | ||
2-241685863-T-G | not specified | Uncertain significance (Feb 28, 2024) | ||
2-241686678-G-C | not specified | Uncertain significance (Nov 11, 2024) | ||
2-241686681-G-A | Benign (Mar 29, 2018) | |||
2-241686698-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
2-241686699-C-A | not specified | Uncertain significance (Jul 14, 2023) | ||
2-241686732-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
2-241686747-C-T | not specified | Uncertain significance (Apr 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DTYMK | protein_coding | protein_coding | ENST00000305784 | 5 | 11250 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000615 | 0.488 | 125709 | 0 | 39 | 125748 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.251 | 122 | 130 | 0.938 | 0.00000856 | 1362 |
Missense in Polyphen | 32 | 44.096 | 0.72569 | 480 | ||
Synonymous | -0.309 | 62 | 59.0 | 1.05 | 0.00000421 | 427 |
Loss of Function | 0.451 | 7 | 8.41 | 0.832 | 3.56e-7 | 103 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000239 | 0.000239 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.0000939 | 0.0000924 |
European (Non-Finnish) | 0.000220 | 0.000220 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of dTMP to dTDP.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Zidovudine Pathway, Pharmacokinetics/Pharmacodynamics;Pyrimidine metabolism;pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates;Metabolism;superpathway of pyrimidine deoxyribonucleoside salvage;Pyrimidine nucleotides nucleosides metabolism;pyrimidine deoxyribonucleotide phosphorylation;superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis;pyrimidine deoxyribonucleotides biosynthesis from CTP
(Consensus)
Recessive Scores
- pRec
- 0.272
Intolerance Scores
- loftool
- 0.368
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.26
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.376
- ghis
- 0.701
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.966
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dtymk
- Phenotype
Gene ontology
- Biological process
- nucleoside diphosphate phosphorylation;dUDP biosynthetic process;dTDP biosynthetic process;dTTP biosynthetic process;cell population proliferation;nucleobase-containing small molecule interconversion;response to estrogen;myoblast differentiation;response to cadmium ion;nucleoside monophosphate phosphorylation;cellular response to growth factor stimulus
- Cellular component
- nucleus;cytoplasm;mitochondrion;mitochondrial intermembrane space;mitochondrial matrix;cytosol
- Molecular function
- nucleoside diphosphate kinase activity;thymidylate kinase activity;ATP binding;uridylate kinase activity;nucleoside monophosphate kinase activity